David Mark Milch - 18 Mar 2026 Form 3 Insider Report for Alpha Tau Medical Ltd. (DRTS)

Role
Director
Signature
/s/ David M. Milch
Issuer symbol
DRTS
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 19:01:12 UTC
Previous filing
09 Mar 2022
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MILCH DAVID MARK Director C/O ALPHA TAU MEDICAL, PO BOX 45044, JERUSALEM, ISRAEL /s/ David M. Milch 18 Mar 2026 0001233803

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DRTS Ordinary Shares 29,367 18 Mar 2026 Direct
holding DRTS Ordinary Shares 88,743 18 Mar 2026 Held through entity under his control, Healthcare Capital Sponsor LLC
holding DRTS Restricted Share Units 4,680 18 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DRTS Options 18 Mar 2026 Ordinary Shares 8,945 $10.92 Direct F2
holding DRTS Options 18 Mar 2026 Ordinary Shares 10,178 $7.19 Direct F2
holding DRTS Options 18 Mar 2026 Ordinary Shares 46,905 $3.28 Direct F2
holding DRTS Options 18 Mar 2026 Ordinary Shares 43,257 $2.98 Direct F2
holding DRTS Options 18 Mar 2026 Ordinary Shares 24,460 $4.05 Direct F2
holding DRTS Options 18 Mar 2026 Ordinary Shares 15,527 $6.41 Direct F3
holding DRTS Warrants 18 Mar 2026 Ordinary Shares 49,000 $11.50 Held through entity under his control, Healthcare Capital Sponsor LLC F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These ordinary shares represent restricted share units, which will vest in their entirety upon the earlier of: one year commencing from March 9, 2026 or the next Annual General Meeting of Shareholders, subject to the Reporting Person's continued service.
F2 These are options to acquire ordinary shares, which have fully vested as of the date hereof.
F3 These are options to acquire ordinary shares, which options will vest in their entirety upon the earlier of: one year commencing from March 9, 2026 or the next Annual General Meeting of Shareholders, subject to the Reporting Person's continued service.
F4 these are warrants to acquire ordinary shares, which have fully vested as of the date hereof.